Citadel Advisors
IBDX icon

Citadel Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Citadel Advisors’s Portfolio IBDX Stock Details IBDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Sell
11,514
-19,646
-63% -$495K ﹤0.01% 11187
2026
Q1 		$787K Buy
+31,160
New +$795K ﹤0.01% 8225
2025
Q4 		– Sell
-228,866
Closed -$5.86M – 13266
2025
Q3 		$5.86M Sell
228,866
-18,826
-8% -$478K ﹤0.01% 4064
2025
Q2 		$6.26M Buy
247,692
+19,094
+8% +$474K ﹤0.01% 3737
2025
Q1 		$5.71M Buy
228,598
+177,910
+351% +$4.4M ﹤0.01% 3668
2024
Q4 		$1.25M Sell
50,688
-35,130
-41% -$879K ﹤0.01% 6572
2024
Q3 		$2.21M Buy
85,818
+36,354
+73% +$918K ﹤0.01% 5346
2024
Q2 		$1.21M Buy
49,464
+20,237
+69% +$494K ﹤0.01% 6224
2024
Q1 		$725K Sell
29,227
-276,340
-90% -$6.85M ﹤0.01% 7594
2023
Q4 		$7.71M Buy
305,567
+236,651
+343% +$5.65M ﹤0.01% 3181
2023
Q3 		$1.62M Buy
+68,916
New +$1.66M ﹤0.01% 5608

Other funds holding IBDX

ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SIC
Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

Citadel Advisors's IBDX Position: Q2 2026 in Review

Citadel Advisors reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 63% in Q2 2026, selling an estimated $495K and leaving 11,514 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #11187.

Citadel Advisors first reported a position in IBDX in Q3 2023 and has held it in 11 quarters since. The position peaked at $7.71M in Q4 2023. 229 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Citadel Advisors held 11,514 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $290K as of Q2 2026.
  • Citadel Advisors sold 19,646 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $495K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11187 holding.
  • Citadel Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2023 and has held it in 11 quarters since.
  • Citadel Advisors's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $7.71M in Q4 2023.
  • 229 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.